Minutes of seminar on 2023 multi-center cooperation project of liver transplantation for metastatic liver cancer in China
-
摘要: 由浙江大学郑树森院士领衔，汇集全国28家肝移植中心的中国首个转移性肝癌肝移植多中心合作项目在上海启动，围绕转移性肝癌肝移植入组条件、转移性肝癌肝移植风险评估与预后判断、转移性肝癌肝移植围手术期用药、多中心合作项目实施细节四项议题，与会专家展开深入交流和讨论，并以调查问卷形式凝聚共识、明确方向，致力于推动国内高质量规范化开展转移性肝癌肝移植临床研究。Abstract: Led by Zheng Shusen, Academician of Chinese Academy of Engineering (CAE) from Zhejiang University, the first multi-center cooperation project of liver transplantation for metastatic liver cancer in China, gathering 28 liver transplantation centers nationwide, was launched in Shanghai. All participating experts conducted in-depth exchanges and discussions regarding four topics including inclusion criteria of liver transplantation for metastatic liver cancer, the risk assessment and prognostic evaluation of liver transplantation for metastatic liver cancer, perioperative medication of liver transplantation for metastatic liver cancer, and the implementation details of multi-center cooperation project. Questionnaires were distributed to reach consensus and pinpoint the directions, aiming to carry out high-quality and standardized clinical researches on liver transplantation for metastatic liver cancer in China.
-
[1] DUELAND S, SYVERSVEEN T, SOLHEIM JM, et al. Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases[J]. Ann Surg, 2020, 271(2): 212-218. DOI: 10.1097/SLA.0000000000003404. [2] HERNANDEZ-ALEJANDRO R, RUFFOLO LI, SASAKI K, et al. Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases[J]. JAMA Surg, 2022, 157(6): 524-530. DOI: 10.1001/jamasurg.2022.0300. [3] BONNEY GK, CHEW CA, LODGE P, et al. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines[J]. Lancet Gastroenterol Hepatol, 2021, 6(11): 933-946. DOI: 10.1016/S2468-1253(21)00219-3. [4] 中国医师协会外科医师分会, 中华医学会外科学分会胃肠外科学组, 中华医学会外科学分会结直肠外科学组, 等. 中国结直肠癌肝转移诊断和综合治疗指南(2023版)[J]. 中华消化外科杂志, 2023, 22(1): 1-28. DOI: 10.3760/cma.j.cn115610-20221228-00762.Branch of Surgeons of Chinese Medical Doctor Association, Gastrointestinal Surgery Group of Branch of Surgery of Chinese Medical Association, Colorectal Surgery Group of Branch of Surgery of Chinese Medical Association. Chinese guidelines for diagnosis and comprehensive treatment of colorectal liver metastases (2023 edition)[J]. Chin J Dig Surg, 2023, 22(1): 1-28. DOI: 10.3760/cma.j.cn115610-20221228-00762. [5] NGUYEN NT, HARRING TR, GOSS JA, et al. Neuroendocrine liver metastases and orthotopic liver transplantation: the US experience[J]. Int J Hepatol, 2011: 742890. DOI: 10.4061/2011/742890. [6] LE TREUT YP, GRÉGOIRE E, KLEMPNAUER J, et al. Liver transplantation for neuroendocrine tumors in Europeresults and trends in patient selection: a 213-case European Liver Transplant Registry study[J]. Ann Surg, 2013, 257(5): 807-815. DOI: 10.1097/SLA.0b013e31828ee17c. [7] SUNG H, FERLAY J, SIEGEL RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660. [8] SPOSITO C, DROZ DIT BUSSET M, CITTERIO D, et al. The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors: pros and cons[J]. Rev Endocr Metab Disord, 2017, 18(4): 473-483. DOI: 10.1007/s11154-017-9439-7. [9] DUELAND S, GRUT H, SYVERSVEEN T, et al. Selection criteria related to long-term survival following liver transplantation for colorectal liver metastasis[J]. Am J Transplant, 2020, 20(2): 530-537. DOI: 10.1111/ajt.15682. [10] LUO Y, TENG F, FU H, et al. Immunotherapy in liver transplantation for hepatocellular carcinoma: pros and cons[J]. World J Gastrointest Oncol, 2022, 14(1): 163-180. DOI: 10.4251/wjgo.v14.i1.163. -
下载:
点击查看大图
图(2)
计量
- 文章访问数: 220
- HTML全文浏览量: 115
- PDF下载量: 35
- 被引次数: 0
